Atridox from Oraldent is a pharmaco-mechanical, one-session therapy for early detected periodontitis and is for use in adults with chronic periodontitis at sites with probing depths of 5mm or more, as an adjunct to conventional non-surgical management of periodontal disease.

The product is a viscous gel that easily flows into areas difficult to instrument, such as furcations. It lines the pocket and once in contact with the crevicular fluid, it precipitates and quickly becomes wax-like and remains in the pocket.

When Atridox is applied, it releases doxycyline over a prolonged period. The concentration in the pockets reaches several hundred times the MIC90 for the perio-pathogens and it remains at these high levels for at least seven days.

The substantivity helps reduce the microorganisms residing in these tissues. Oraldent believes that the clinical result is equivalent to or even better than that achieved with scaling and root planing and hard tissue damage is reduced.

Reader response number 56